celgene_exteriors-3

Celgene hikes price of Revlimid to mask poor Q3 results

October 27, 2017
Medical Communications, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical

Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …

abbvieuse_054_low

AbbVie’s psoriasis drug smashes all endpoints

October 26, 2017
Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab

AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …

amber_hr_2

Is the NHS prepared for the upcoming winter season?

October 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …

gsk_wall

GSK eyes healthcare expansion, hits targets due to new drugs

October 26, 2017
Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical

During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …

Pfizer to begin auction of consumer health division next month

October 26, 2017
Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …

doctor-840127_960_720

NHS patients could be offered Airbnb-like accommodation

October 26, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting …

regeneron

Regeneron injects $100 million and 300 new roles into Irish production facility

October 26, 2017
Manufacturing and Production Regeneron, Sanofi, manufacturing, pharma

Sanofi subsidiary Regeneron has announced its intention to expand its production plant in Limerick, Ireland – the largest scale bulk …

Mental health problems cause 300,000 to leave work each year

October 26, 2017
Research and Development biotech, drugs, mental health, pharma, pharmaceutical

A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …

Sanofi launches patent infringement lawsuit against Mylan over diabetes pen

October 25, 2017
Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …

lilly2_web

Lilly looks to leave behind animal health business

October 25, 2017
Research and Development, Sales and Marketing Elanco, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …

GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost

October 25, 2017
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …

8384110298_da510e0347_c

Research finds blood-thinners protect against dementia

October 25, 2017
Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …

diabetes-2424105_960_720

Type 3 diabetes more common than Type 1 and often misdiagnosed

October 25, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …

Novartis Q3: Jimenez talks up Alcon, Gleevec takes generic hammering

October 24, 2017
Manufacturing and Production, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical

Novartis released its Q3 financials and, despite Gleevec dipping significantly due to generic competition, still managed to report sales of …

alessandro-riva

Gilead promotes Alessandro Riva to Senior VP, Hematology and Oncology Therapeutic Area Head

October 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …

shutterstock_138095450

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide

October 24, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

handshake

Eisai banks on potential of Biogen’s Alzheimer’s drug

October 24, 2017
Manufacturing and Production, Sales and Marketing

Drug developers investigating Alzheimer’s drugs know that they’re taking a gamble; there have been numerous big failures that have caused …

pounds_stacked

ADC Therapeutics brings in $200 million of financing

October 24, 2017
Manufacturing and Production, Sales and Marketing ADC Therapeutics, AstraZeneca, biotech, drugs, pharma, pharmaceutical

ADC Therapeutics has won some serious financial support after its latest financing round managed to net the company $200 million. …

Recipharm equips Lisbon facility for US and European serialisation

October 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …

The Gateway to Local Adoption Series

Latest content